Maria Sharapova of Russia wipes her face during her match against Serena Williams of the U.S.A. at the Wimbledon Tennis Championships in London, July 9, 2015. REUTERS/Toby Melville
Russian tennis star Maria Sharapova said on Monday she had failed a drug test at the Australian Open due to a substance she was taking for health issues, leading longtime sponsor Nike to announce it was suspending ties during the investigation, Reuters reports.
The 28-year-old Sharapova, a five-time grand slam champion and the highest paid woman in sports, will be provisionally suspended starting March 12, the International Tennis Federation (ITF) said.
She is the seventh athlete in a month to test positive for meldonium, which is used to treat diabetes and low magnesium, and was only banned by the World Anti-Doping Agency (WADA) as of Jan. 1.
“I made a huge mistake. I let my fans down and I let the sport down,” said Sharapova, a teenage tennis prodigy who became the third-youngest Wimbledon champion. “I take full responsibility for it.”
Advertisement
“I know that with this I face consequences and I don’t want to end my career this way. I really hope that I will be given another chance to play this game,” former world number one Sharapova told a news conference in a downtown Los Angeles hotel.
Nike, the world’s largest sportswear maker, said it was “saddened and surprised” by the news and released a statement saying it was putting ties on hold with the player.
“We have decided to suspend our relationship with Maria while the investigation continues,” it said.
Advertisement
The ITF’s anti-doping program calls for a four-year suspension for a positive test, but that ban can be reduced in various circumstances, such as for first-time offences or if the player shows no significant fault or negligence.
If a player bears no fault or negligence, there is no suspension.
